Evidence map›Paper›PMID 15537847›Full record

ReviewPostgraduate medical journal2004

Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.

M E Onwuamaegbu, M Henein, A J Coats

Open access · bronzeAbstract readReview
In one paragraph

Review in Postgraduate medical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. The intersection of hostMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  3. Article
  4. Immunomodulatory effects of testosterone and letrozole duringFrontiers in cellular and infection microbiology · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Cachexia as a major public health problem: frequent, costly, and deadly.Journal of cachexia, sarcopenia and muscle · 2013
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

M E OnwuamaegbuDepartment of Clinical Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. drmeto@doctors.net.uk
M Henein
A J Coats
Royal Brompton Hospital · GBUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cachexia is an independent prognostic marker of survival in many chronic diseases including heart failure and malaria. Morbidity and mortality from malaria is high in most of the third world where it presents a very challenging public health problem. Malaria may present in the UK as fever in the returning traveller or as fever in overseas visitors. How and why cachexia develops in malaria in a manner similar to the cachexia of chronic heart failure and the treatment strategies that would alter outcomes in both diseases are discussed in this review.

Indexed as

CachexiaCytokinesHeart FailureHumansLipidsMalariaPrognosisTumor Necrosis Factor-alphaCytokinesLipidsTumor Necrosis Factor-alpha

Identifiers

PMID15537847
PMCPMC1743137
OpenAlexW2131649391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.